Crispr Therapeutics AG (CRSP) financials · rev $3.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Crispr Therapeutics AG (CRSP) rev $3.5M.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $3.51M | $37.31M | |
| Operating Income | −$664.57M | −$466.57M | |
| Net Income | −$581.60M | −$366.25M | |
| EPS (Diluted) | −$6.47 | −$4.34 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $2.27B | $2.24B | |
| Current Assets | $1.99B | $1.94B | |
| Cash & Equivalents | $347.56M | $298.26M | |
| PP&E | $115.85M | $134.09M | |
| Total Liabilities | $343.43M | $309.95M | |
| Current Liabilities | $149.12M | $87.78M | |
| Long-term Debt | — | — | |
| Shareholders' Equity | $1.92B | $1.93B | |
| Retained Earnings | −$1.95B | −$1.37B |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$345.01M | −$142.77M | |
| CapEx | $914.00K | $1.90M | |
| Investing Cash Flow | −$31.80M | −$280.48M | |
| Financing Cash Flow | $426.03M | $331.98M | |
| Net Change in Cash | $49.30M | −$91.29M | |
| Free Cash Flow | −$345.93M | −$144.68M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is CRSP P/E and revenue?
Crispr Therapeutics AG (CRSP) rev $3.5M.
What is CRSP revenue?
Crispr Therapeutics AG last cached revenue is $3.51M (FY2025).
Is CRSP profitable?
Crispr Therapeutics AG last cached net income is -$581.6M (FY2025).
What are CRSP total assets?
Crispr Therapeutics AG last cached total assets are $2.27B (FY2025).
What is CRSP free cash flow?
Crispr Therapeutics AG last cached free cash flow is -$345.9M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.